Sonoma Pharmaceuticals, Inc. — Director's Dealing 2021

Jan 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sonoma Pharmaceuticals, Inc. (SNOA)
CIK: 0001367083
Period of Report: 2021-01-07

Reporting Person: Trombly Amy Moss (Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-07	Stock option (right to buy)	$8.03	A	27777	Acquired	2031-01-07	Common Stock (27777)	Direct

Footnotes

F1: The options vest one third each on 01/07/2022, 01/07/2023 and 01/07/2024, or upon change of control.

F2: The options were awarded and granted to Ms. Trombly for services performed.